| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Options Exercise | $375K | +5.9K | +61.72% | $63.55 | 15.5K | Jun 27, 2022 | Direct | F1 |
| transaction | XYL | Common Stock | Sale | -$472K | -5.9K | -38.16% | $80.06 | 9.56K | Jun 27, 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -5.9K | -49.26% | $0.00 | 6.08K | Jun 27, 2022 | Common Stock | 5.9K | $63.55 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. |
| F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were sold at a range of prices from $80.00 to $80.31. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F3 | The May 7, 2020 option grant vests in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023. |